DCF — ST. CHARLES MED CTR - PRINEVILLE
Enterprise Value: $39.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$39.8M
Enterprise Value
$10.1M
PV of Cash Flows
$29.6M
PV of Terminal Value
$47.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $64.3M | $5.5M | 9.0% | $1.8M | $1.6M |
| Year 2 | $66.2M | $6.3M | 10.0% | $2.3M | $1.9M |
| Year 3 | $68.2M | $7.2M | 11.0% | $2.9M | $2.2M |
| Year 4 | $70.2M | $7.7M | 11.0% | $3.3M | $2.2M |
| Year 5 | $72.3M | $8.1M | 11.0% | $3.5M | $2.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $39.8M. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$62.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.0800000006411627
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5